Remove 2027 Remove Healthcare Remove Side effects
article thumbnail

Telehealth use drops as hype expires

World of DTC Marketing

Billion by 2027, growing at a CAGR of 16.4% from 2020 to 2027. ” An Oncology practice uses telehealth to talk with patients who have just undergone chemo to check on their status and help them deal with the side effects. According to Verified Market Research, the Global Telehealth Market was valued at USD 21.17

article thumbnail

How to Successfully Market Your GLP-1 Program: Strategies for Standing Out

LEVO Health

billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Educational Content Provide patients with comprehensive information about GLP-1 medications, their benefits, potential side effects, and how they work.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novartis takes aim at MS blockbuster Tysabri in US and Europe

pharmaphorum

There was also continued decline for Tecfidera, which have not been offset by follow-up Vumerity (diroximel fumarate), which has fewer side effects. It had expected the drug would not face biosimilar competition in Europe until at least 2027. The subcutaneous version still needs to be administered by a healthcare professional.

article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion by 2027. The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 98